You are viewing: India IVD Raw Material Market analysis
Part of: IVD Raw Material Market (Global)

The India IVD Raw Material Market was valued at $292.4 Million in 2026 and projected to reach to $440.2 Million by 2031, representing a compound annual growth rate of 8.5%. India's IVD raw material market is poised for accelerated growth driven by increasing healthcare expenditure, rising disease prevalence, and the country's emergence as a preferred manufacturing destination.

India IVD Raw Material Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India IVD Raw Material Market Trends and Insights

  • This growth trajectory reflects India's strengthening position as a global hub for diagnostic manufacturing and increasing domestic demand for advanced healthcare solutions.
  • India's market expansion is driven by rising prevalence of chronic diseases, growing laboratory infrastructure, and government initiatives supporting diagnostic accessibility across urban and rural regions. The Indian IVD raw material sector benefits from a large population base, expanding middle-class healthcare spending, and the country's established pharmaceutical and biotechnology ecosystem.
  • India's competitive advantage in cost-effective production and skilled workforce attracts both domestic and international diagnostic manufacturers seeking raw material suppliers.
  • Between 2026 and 2031, India is expected to capture increasing market share within the Asia Pacific region, supported by regulatory improvements and investments in quality assurance standards that enhance India's credibility in global supply chains..

Key Market Statistics

  • CAGR (2026-2031) 8.5% CAGR
  • Market Size, 2026 ~USD 292.4 Million
  • Forecast, 2031 ~USD 440.2 Million
  • Country India

India IVD Raw Material Market Overview

Market Valuation Growth :

India's IVD raw material market is valued at USD 292.4 million in 2026 and is projected to grow to USD 440.2 million by 2031, representing a robust 8.5% CAGR, outpacing the global growth rate of 7.7%.

Global Manufacturing Hub Status :

India is establishing itself as a critical global hub for diagnostic manufacturing, leveraging cost advantages, skilled workforce, and regulatory expertise to attract international IVD raw material suppliers and manufacturers.

Rising Healthcare Demand :

Increasing prevalence of chronic diseases, expanding healthcare infrastructure, and growing awareness of preventive diagnostics are driving substantial demand for IVD raw materials across India's domestic market.

Regulatory and Infrastructure Development :

Strengthening regulatory frameworks, government initiatives like Make in India, and investments in diagnostic infrastructure are creating favorable conditions for IVD raw material market expansion and localization.

India IVD Raw Material Market Dynamics

  • The 8.5% CAGR reflects strong domestic demand coupled with India's competitive advantages in cost-effective production and quality compliance.
  • Government support through regulatory harmonization and infrastructure development further strengthens market fundamentals.
  • By 2031, the market's expansion to USD 440.2 million will be underpinned by growing diagnostic testing volumes, pharmaceutical sector expansion, and rising adoption of advanced diagnostic technologies across urban and semi-urban regions..

Market Ecosystem

logo-mobile

IVD RAW MATERIAL MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Supplies antibodies, antigens, recombinant proteins, enzymes, membranes, and other critical raw materials used in the development of immunoassays, molecular diagnostics, and point-of-care tests. Enables high assay sensitivity and specificity, ensures consistent test performance, and supports scalable diagnostic manufacturing.
company logo
Provides a broad portfolio of antibodies, proteins, enzymes, nucleic acids, and specialty reagents for diagnostic assay development and commercialization. Supports reliable assay development, improves diagnostic accuracy, and accelerates time-to-market for IVD manufacturers.
company logo
Develops and manufactures diagnostic-grade antibodies, antigens, and assay components for immunodiagnostic and rapid testing applications. Enhances assay performance, ensures batch-to-batch consistency, and supports high-quality diagnostic outcomes.
company logo
Offers recombinant proteins, antibodies, immunoassay reagents, and molecular diagnostic raw materials for clinical and research diagnostic applications. Provides high analytical sensitivity, supports biomarker detection, and enables development of advanced diagnostic tests.
company logo
Supplies integrated raw material solutions including antibodies, antigens, enzymes, and detection reagents for immunoassays and point-of-care diagnostics. Facilitates cost-effective assay development, improves diagnostic reliability, and supports large-scale manufacturing requirements.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • India's IVD raw material market is valued at USD 292.4 million in 2026, with a projected CAGR of 8.5% through 2031.
    • India's market is expected to reach USD 440.2 million by 2031, driven by rising chronic disease prevalence and expanding laboratory infrastructure.
    • India's cost-competitive manufacturing and skilled workforce position the country as a preferred supplier for global diagnostic manufacturers.
    • India's regulatory improvements and quality assurance investments are strengthening its role within the Asia Pacific IVD raw material supply chain.

    IVD Raw Material Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026-2031
    Growth Rate CAGR of 7.7% from 2026 to 2031
    Largest Segment IVD MANUFACTURERS (End User)
    Market Size Base Year (Billions) ~USD 21.46 (2026)
    Revenue Forecast (Billions) ~USD 31.1 (2031)
    Segments Covered Product Type, Type, Technology, Application, Supply Source, Source/Origin, End User

    India IVD Raw Material Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product Type

    • Antibodies
    • Antigens & Proteins
    • Beads & Particles
    • Buffers & Diluents
    • Enzymes & Substrates
    • Labels & Detection Materials
    • Membranes
    • Oligonucleotides & Nucleic Acids
    • Other Products

    By Type

    • Academic & Research Institutes
    • Amplification Enzymes
    • Animal-Derived
    • Calibrators & Standards
    • Chemically Synthesized
    • Chemiluminescent Labels
    • Cho-Expressed
    • Colloidal Gold Conjugates
    • Cros
    • Detection Enzymes
    • E. Coli-Expressed
    • Fluorescent Dyes
    • Glass Fiber Pads
    • Gold Nanoparticles
    • Human-Derived
    • Ivd Manufacturers
    • Latex Particles
    • Magnetic Beads
    • Monoclonal Antibodies
    • Native Proteins
    • Nitrocellulose Membranes
    • Nylon & Pvdf Membranes
    • Other End Users
    • Pharmaceutical & Biotechnology Companies
    • Polyclonal Antibodies
    • Primers & Probes
    • Recombinant Antibodies
    • Recombinant Antigens
    • Substrates & Coenzymes
    • Synthetic Dna/Rna

    By Technology

    • Clinical Chemistry
    • Coagulation Testing
    • Flow Cytometry
    • Hematology
    • Immunoassay
    • Microbiology & Culture
    • Molecular Diagnostics
    • Other Technologies

    By Application

    • Autoimmune Diseases
    • Blood Screening
    • Cardiac Markers
    • Diabetes & Metabolic Disorders
    • Genetic & Rare Disease Testing
    • Infectious Diseases
    • Oncology/Cancer Markers
    • Other Applications
    • Women'S Health & Fertility

    By Supply Source

    • In-House Manufacturing
    • Third-Party Supply

    By Source/Origin

    • Biological/Natural Sources
    • Other Sources
    • Recombinant/ Synthetic Sources
    • Recombinant/Synthetic Sources

    By End User

    • Academic & Research Institutes
    • Cros
    • Ivd Manufacturers
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    Target Audience

    • IVD Raw Material Manufacturers : Manufacturers need India-specific market data to assess production capacity requirements, localization opportunities, and competitive positioning within the fastest-growing diagnostic manufacturing hub in Asia.
    • Diagnostic Equipment Producers : Equipment manufacturers require detailed insights into India's raw material supply landscape, sourcing costs, and supplier capabilities to optimize supply chain strategies and ensure reliable component availability for Indian operations.
    • Healthcare & Pharmaceutical Companies : Healthcare organizations and pharma companies need market intelligence on India's diagnostic infrastructure growth and raw material availability to plan diagnostic service expansion and in-house testing capabilities.
    • Investment & Private Equity Firms : Investors require validated market sizing, growth projections, and India-specific opportunity analysis to identify high-potential investment targets in the IVD raw material sector and assess portfolio company expansion strategies.
    • Government & Policy Bodies : Regulatory agencies and government bodies need comprehensive market data to inform healthcare policy, manufacturing incentives, and diagnostic infrastructure development initiatives aligned with India's healthcare modernization goals.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for India's IVD raw material market (USD 292.4M in 2026) with verified 8.5% CAGR projections through 2031, enabling accurate business planning and investment decisions specific to the Indian market.
    • Competitive Positioning Intelligence : Understand India's competitive advantages as a global manufacturing hub, including cost structures, regulatory compliance capabilities, and supply chain dynamics to benchmark against regional competitors and identify market entry opportunities.
    • Demand Driver Analysis : Access detailed insights into India-specific demand drivers including disease prevalence trends, healthcare infrastructure expansion, and diagnostic testing volume growth to align product development and market strategies with local market needs.
    • Regulatory & Policy Landscape : Gain comprehensive understanding of India's evolving regulatory framework, government initiatives (Make in India), and compliance requirements essential for successful market entry, localization, and long-term operational sustainability.
    • Strategic Investment Guidance : Leverage India-focused market forecasts and growth trajectory analysis to identify optimal investment timing, partnership opportunities, and expansion strategies within the high-growth IVD raw material segment through 2031.

    Frequently asked questions

    What is the current size of India's IVD raw material market?

    India's IVD raw material market is valued at USD 292.4 million in 2026 and is projected to grow to USD 440.2 million by 2031.

    What is the expected growth rate for India's IVD raw material market?

    India's IVD raw material market is expected to grow at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2031.

    What factors are driving growth in India's IVD raw material market?

    India's market growth is driven by rising chronic disease prevalence, expanding laboratory infrastructure, government healthcare initiatives, and increasing middle-class healthcare spending.

    Why is India a preferred location for IVD raw material manufacturing?

    India offers cost-competitive production, a skilled workforce, established pharmaceutical and biotechnology infrastructure, and improving regulatory standards that attract global diagnostic manufacturers.

    How does India's IVD raw material market compare within Asia Pacific?

    India is strengthening its position as a key supplier within the Asia Pacific region, leveraging its manufacturing capabilities and quality improvements to capture increasing market share.

    RESEARCH METHODOLOGY

    The objective of this study is to analyze the key dynamics influencing the IVD raw material market, including drivers, restraints, opportunities, challenges, and emerging technology trends. The study also evaluates competitive developments, including product launches, regulatory approvals, acquisitions, partnerships, collaborations, and geographic expansions undertaken by leading market participants. Furthermore, it assesses the competitive landscape of the IVD raw material market by profiling key players and benchmarking them across various business and product strategy parameters. Both top-down and bottom-up approaches were employed to estimate the overall market size, while market breakdown and data triangulation methodologies were used to validate the size of individual segments and subsegments and ensure the accuracy of market estimates.

    The four steps involved in estimating the market size are as follows:

    Secondary Research

    Secondary research for the IVD raw material market drew on a wide range of credible commercial and regulatory sources, including Bloomberg Business, Factiva, and Dun & Bradstreet for corporate financial and operational data. White papers, scientific publications, annual reports, investor presentations, and SEC filings provided additional context on product pipelines, revenue structures, and market positioning. Regulatory databases were used to track device clearances and approvals in key geographies.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Supply-side primary interviews were conducted with project managers, product managers, sales directors, vice presidents of diagnostics, CEOs, and business development directors at manufacturers of IVD raw material, laboratory automation vendors, and IVD distributors. Demand-side primary interviews covered laboratory directors and clinical pathologists at hospital and reference laboratories, forensic laboratory managers, reproductive health clinic directors, academic research scientists, and procurement officers at pharmaceutical and biotechnology companies.

    The following is a breakdown of the primary respondents:

    IVD Raw Material Market Size, and Share

    Note: Others include sales, marketing, and product managers.
    Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    COMPANY NAME

    DESIGNATION

    Merck KGaA (Germany)

    Sales Manager

    Thermo Fisher Scientific Inc. (US)

    Product Manager

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the IVD raw material market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the IVD raw material market were determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    IVD Raw Material Market : Top-Down and Bottom-Up Approach

    IVD Raw Material Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size using the process described above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed to validate and complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments of the IVD raw material market. The data was triangulated by examining various factors and trends on the demand and supply sides of the IVD raw material market.

    Market Definition

    The IVD raw material market is the industry involved in the development, production, and supply of biological, chemical, and synthetic components used in manufacturing in vitro diagnostic (IVD) assays and testing systems. These raw materials include antibodies, antigens, proteins, enzymes, substrates, oligonucleotides, nucleic acids, beads and particles, membranes, labels and detection materials, buffers, diluents, and other specialized reagents that serve as critical building blocks for diagnostic tests. IVD raw materials are utilized across a wide range of diagnostic technologies. These materials play a vital role in ensuring the accuracy, sensitivity, specificity, and reliability of diagnostic tests used to detect, diagnose, screen for, monitor, and prognose health-related conditions.

    Key Stakeholders

    • IVD Raw Material Manufacturers and Suppliers
    • IVD Manufacturers (OEMs/Diagnostic Kit Manufacturers)
    • Contract Research Organizations (CROs) and Contract Development & Manufacturing Organizations (CDMOs)
    • Diagnostic Laboratories and Clinical Testing Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Research and Development (R&D) Centers
    • Distributors and Channel Partners
    • Regulatory and Quality Compliance Organizations
    • Healthcare Institutions and Diagnostic Service Providers

    Report Objectives

    • To define, describe, and forecast the IVD raw material market by product type, technology, application, supply source, source/origin, end user, and region
    • To provide detailed information about the key factors influencing the growth of the IVD raw material market (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide the competitive landscape details of the key players
    • To forecast the revenue of market segments across five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players of the IVD raw material market and comprehensively analyze their core competencies and market shares
    • To benchmark players within the market using the proprietary company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI on the market, along with the macroeconomic outlook for each region

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Country Information

    • Additional country-level analysis of the IVD raw material market

    Company Profiles

    • Additional five company profiles of players operating in the IVD raw material market.

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the IVD raw material market

    Get the Full IVD Raw Material Market Report

    Full forecast, segment splits, and company analysis for all IVD Raw Material Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status